The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Frackowiak, R. S. J. (1997) · Cited by 1,795
(1995) · PubMed Central · doi:10.2967/jnumed.120.252510a · Cited by 996
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
Herholz, K., Salmon, E., Perani, D., Baron, J.-C., Holthoff, V., Frölich, L., Schönknecht, P., Ito, K., Mielke, R., & Kalbe, E. (2002) · NeuroImage · doi:10.1006/nimg.2002.1208 · Cited by 832 · cited 1×
“Indications include early diagnosis and differential diagnosis of dementing disorders, such as Alzheimer’s disease and frontotemporal dementia [8–10].”
BackgroundMosconi, L., Tsui, W. H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., Reiman, E. M., Holthoff, V., Kalbe, E., Sorbi, S., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045385 · Cited by 726 · cited 1×
“Indications include early diagnosis and differential diagnosis of dementing disorders, such as Alzheimer’s disease and frontotemporal dementia [8–10].”
BackgroundPET: the merging of biology and imaging into molecular imaging.
Phelps, M. E. (2000) · PubMed · Cited by 531
FDG PET in the differential diagnosis of parkinsonian disorders
Eckert, T., Barnes, A., Dhawan, V., Frucht, S., Gordon, M. F., Feigin, A. S., & Eidelberg, D. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.03.012 · Cited by 419
Kaschten, B., Stevenaert, A., Sadzot, B., Deprez, M., Degueldre, C., Fiore, G. D., Luxen, A., & Reznik, M. (1998) · PubMed · Cited by 327
Positron emission tomography imaging in dementia
HERHOLZ, K., CARTER, S. F., & JONES, M. (2007) · The British Journal of Radiology · doi:10.1259/bjr/97295129 · Cited by 287
Minoshima, S., Koeppe, R. A., Mintun, M. A., Berger, K. L., Taylor, S. F., Frey, K. A., & Kuhl, D. E. (1993) · PubMed · Cited by 255
Cited by
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Boellaard, R., Delgado-Bolton, R., Oyen, W. J. G., Giammarile, F., Tatsch, K., Eschner, W., Verzijlbergen, F. J., Barrington, S. F., Pike, L. C., Weber, W. A., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2961-x · Cited by 3,303
“& When dedicated brain imaging is indicated, additional preparation is necessary [39].”
InfluentialSelf-citationStrategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Frisoni, G. B., Boccardi, M., Barkhof, F., Blennow, K., Cappa, S., Chiotis, K., Démonet, J.-F., Garibotto, V., Giannakopoulos, P., Gietl, A., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30159-x · Cited by 626
Self-citationLaw, I., Albert, N. L., Arbizu, J., Boellaard, R., Drzezga, A., Galldiks, N., la Fougère, C., Langen, K.-J., Lopci, E., Lowe, V., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4207-9 · Cited by 556
Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19
Hosp, J. A., Dressing, A., Blazhenets, G., Bormann, T., Rau, A., Schwabenland, M., Thurow, J., Wagner, D., Waller, C., Niesen, W. D., et al. (2021) · Brain · doi:10.1093/brain/awab009 · Cited by 384
Blood-brain barrier opening with focused ultrasound in Parkinson’s disease dementia
Gasca-Salas, C., Fernández-Rodríguez, B., Pineda-Pardo, J. A., Rodríguez-Rojas, R., Obeso, I., Hernández-Fernández, F., del Álamo, M., Mata, D., Guida, P., Ordás-Bandera, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21022-9 · Cited by 319
Positron Emission Tomography (PET) in Oncology
Gallamini, A., Zwarthoed, C., & Borra, A. (2014) · Cancers · doi:10.3390/cancers6041821 · Cited by 312
EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
Guedj, E., Varrone, A., Boellaard, R., Albert, N. L., Barthel, H., van Berckel, B., Brendel, M., Cecchin, D., Ekmekcioglu, O., Garibotto, V., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05603-w · Cited by 300
Self-citationXiang, X., Wind, K., Wiedemann, T., Blume, T., Shi, Y., Briel, N., Beyer, L., Biechele, G., Eckenweber, F., Zatcepin, A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe5640 · Cited by 268
“Emission data of FDG-PET were acquired from 30 to 50 min after injection according to the European Association of Nuclear Medicine (EANM) protocol (67).”
MethodSelf-citationBrain fluorodeoxyglucose (FDG) PET in dementia
Kato, T., Inui, Y., Nakamura, A., & Ito, K. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.02.003 · Cited by 236
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients
Cistaro, A., Pagani, M., Montuschi, A., Calvo, A., Moglia, C., Canosa, A., Restagno, G., Brunetti, M., Traynor, B. J., Nobili, F., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2667-5 · Cited by 129
Self-citationBrain glucose metabolism in Lewy body dementia: implications for diagnostic criteria
Caminiti, S. P., Sala, A., Iaccarino, L., Beretta, L., Pilotto, A., Gianolli, L., Iannaccone, S., Magnani, G., Padovani, A., Ferini-Strambi, L., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0473-4 · Cited by 86
Effects of blood glucose level on 18F-FDG uptake for PET/CT in normal organs: A systematic review
Sprinz, C., Altmayer, S., Zanon, M., Watte, G., Irion, K., Marchiori, E., & Hochhegger, B. (2018) · PLOS ONE · doi:10.1371/journal.pone.0193140 · Cited by 82
Rebelos, E., Rinne, J. O., Nuutila, P., & Ekblad, L. L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071532 · Cited by 66
“Scans can be performed either as dynamic or static emission scans and started either at injection or up to 60 min post-injection [71].”
BackgroundMethodInfluentialMatias-Guiu, J. A., Díaz-Álvarez, J., Cuetos, F., Cabrera-Martín, M. N., Segovia-Ríos, I., Pytel, V., Moreno-Ramos, T., Carreras, J. L., Matías-Guiu, J., & Ayala, J. L. (2019) · Cortex · doi:10.1016/j.cortex.2019.05.007 · Cited by 50
Viglianti, B. L., Wong, K. K., Wimer, S. M., Parameswaran, A., Nan, B., Ky, C., Townsend, D. M., Rubello, D., Frey, K. A., & Gross, M. D. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.166 · Cited by 48
Altered biodistribution on FDG-PET with emphasis on brown fat and insulin effect
Cohade, C. (2010) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2010.02.001 · Cited by 47
Reading prosody in the non-fluent and logopenic variants of primary progressive aphasia
Matias-Guiu, J. A., Suárez-Coalla, P., Pytel, V., Cabrera-Martín, M. N., Moreno-Ramos, T., Delgado-Alonso, C., Delgado-Álvarez, A., Matías-Guiu, J., & Cuetos, F. (2020) · Cortex · doi:10.1016/j.cortex.2020.08.013 · Cited by 20
Metadata
- Authors
- Varrone, A., Asenbaum, S., Vander Borght, T., Booij, J., Nobili, F., Någren, K., Darcourt, J., Kapucu, Ö. L., Tatsch, K., Bartenstein, P., & Van Laere, K.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2009-10-17
- Volume
- 36
- Issue
- 12
- Pages
- 2103-2110
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2095309401
- Cited by
- 544
- References
- 24
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.